"10.1371_journal.pone.0101749","plos one","2014-07-03T00:00:00Z","Vera M Ruda; Rohit Chandwani; Alfica Sehgal; Roman L Bogorad; Akin Akinc; Klaus Charisse; Alexander Tarakhovsky; Tatiana I Novobrantseva; Victor Koteliansky","Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, New York, United States of America","Conceived and designed the experiments: VMR AS RLB AT TIN VK. Performed the experiments: VMR RC AS RLB. Analyzed the data: VMR RC AS RLB TIN VK. Contributed reagents/materials/analysis tools: RC AA KC AT. Wrote the paper: VMR TIN.","AS, AA, KC are current employees/stock holders of Alnylam Pharmaceuticals. TIN and VK are former employees/stock holders of Alnylam Pharmaceuticals. This does not alter the authors adherence to all the PLoS ONE policies, including sharing data and materials. All other authors have declared that no competing interests exist. All authors agree to make freely available the materials and information described in this publication that are reasonably requested by others for the purpose of academic, non-commercial research.","2014","07","Vera M Ruda","VMR",9,FALSE,6,4,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
